125 related articles for article (PubMed ID: 4039917)
1. [The effect of methotrexate on intracellular nucleotide pools].
Kawasaki H; Okubo T; Shimizu N; Komada M; Sako T; Hirota H; Noboru T; Kamiya H; Sakurai M; Izawa T
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):485-92. PubMed ID: 4039917
[TBL] [Abstract][Full Text] [Related]
2. Effect of methotrexate and 1-beta-D-arabinofuranosylcytosine on pools of deoxyribonucleoside triphosphates in L1210 ascites cells.
Roberts D; Peck C
Cancer Res; 1981 Feb; 41(2):505-10. PubMed ID: 7448798
[TBL] [Abstract][Full Text] [Related]
3. [Biochemical modulation in cancer chemotherapy].
Kawasaki H; Nobori T; Kamiya H; Sakurai M
Gan To Kagaku Ryoho; 1985 Apr; 12(4):815-29. PubMed ID: 3985645
[TBL] [Abstract][Full Text] [Related]
4. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
Li ZR; Campbell J; Rustum YM
Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate-induced changes in the levels of 1-beta-D-arabinofuranosylcytosine triphosphate in L1210 cells.
Roberts D; Peck C; Hilliard S; Wingo W
Cancer Res; 1979 Oct; 39(10):4048-54. PubMed ID: 476642
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside: study of L1210 and human leukemic cells.
Cadman E; Eiferman F
J Clin Invest; 1979 Sep; 64(3):788-97. PubMed ID: 288743
[TBL] [Abstract][Full Text] [Related]
7. Role of uridine triphosphate in the phosphorylation of 1-beta-D-arabinofuranosylcytosine by Ehrlich ascites tumor cells.
White JC; Hines LH
Cancer Res; 1987 Apr; 47(7):1820-4. PubMed ID: 3028615
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of ribonucleoside and deoxyribonucleoside triphosphate pools in cultured leukemia cells during exposure to methotrexate or methotrexate plus thymidine.
Kinahan JJ; Otten M; Grindey GB
Cancer Res; 1979 Sep; 39(9):3531-9. PubMed ID: 476679
[TBL] [Abstract][Full Text] [Related]
9. [Use of purine rescue pathways by L1210 cells exposed to methotrexate in vitro].
Buesa JM
Rev Esp Oncol; 1982; 29(4):641-7. PubMed ID: 6085740
[TBL] [Abstract][Full Text] [Related]
10. Enhanced production of intracellular ara-CTP after sequential use of methotrexate and 1-beta-D-arabinofuranosylcytosine.
Nobori T; Okubo T; Shimizu N; Kawasaki H; Sako T; Komada M; Hirota H; Kamiya H; Sakurai M
Leuk Res; 1985; 9(10):1263-5. PubMed ID: 4068748
[TBL] [Abstract][Full Text] [Related]
11. Effects of 2-amino-1,3,4-thiadiazole on ribonucleotide pools of leukemia L1210 cells.
Nelson JA; Rose LM; Bennett LL
Cancer Res; 1976 Apr; 36(4):1375-8. PubMed ID: 130972
[TBL] [Abstract][Full Text] [Related]
12. Dose-related effects of methotrexate on purine and pyrimidine nucleotides and on cell-kinetic parameters in MOLT-4 malignant human T-lymphoblasts.
Bökkerink JP; De Abreu RA; Bakker MA; Hulscher TW; Van Baal JM; De Vaan GA
Biochem Pharmacol; 1986 Oct; 35(20):3557-64. PubMed ID: 2429668
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and cell cycle perturbations in methotrexate-treated cells.
Taylor IW; Slowiaczek P; Francis PR; Tattersall MH
Mol Pharmacol; 1982 Jan; 21(1):204-10. PubMed ID: 6982394
[TBL] [Abstract][Full Text] [Related]
14. Increased activation of 1-beta-D-arabinofuranosylcytosine by hydroxyurea in L1210 cells.
Walsh CT; Craig RW; Agarwal RP
Cancer Res; 1980 Sep; 40(9):3286-92. PubMed ID: 7427943
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of free ribonucleotide pool in the spleens of C57BL and DBA/2 mice and in leukemia cells sensitive and resistant to 5-fluorouracil].
Gerasimova GK; Mokina VD; Sidorova TA
Biokhimiia; 1978 Jan; 43(1):163-9. PubMed ID: 623843
[TBL] [Abstract][Full Text] [Related]
16. Potential for selective enhancement of the in vivo metabolism of 1-beta-D-arabinofuranosylcytosine in rats by thymidine pretreatment.
Danhauser LL; Rustum YM
Cancer Res; 1985 May; 45(5):2002-7. PubMed ID: 3986756
[TBL] [Abstract][Full Text] [Related]
17. Synergistic inhibition of human leukemia cell growth by deoxyguanosine and 1-beta-D-arabinofuranosylcytosine.
Akman SA; Ross DD; Joneckis CC; Fox BM; Bachur NR
Biochem Pharmacol; 1984 Apr; 33(7):1059-63. PubMed ID: 6712715
[TBL] [Abstract][Full Text] [Related]
18. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
Lu P; Lu Y; Pang K; Wang SB; Chen JQ; Xu HM; Wang JK; Zhao SC
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):998-1001. PubMed ID: 16194358
[TBL] [Abstract][Full Text] [Related]
19. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
Taub JW; Huang X; Ge Y; Dutcher JA; Stout ML; Mohammad RM; Ravindranath Y; Matherly LH
Cancer Res; 2000 Nov; 60(22):6421-6. PubMed ID: 11103808
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?
Fairbanks LD; Rückemann K; Qiu Y; Hawrylowicz CM; Richards DF; Swaminathan R; Kirschbaum B; Simmonds HA
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):143-52. PubMed ID: 10432311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]